Orthopedic conditions can affect people in Los Angeles of all ages and lifestyles. While many orthopedic injuries are caused by sudden and severe accidents that inflict a major toll on joints and bones, most are caused by general wear and tear of the joint. Through the gradual loss of cartilage and the weakening of vital connective tissues, joints can lose their normal functions and suffer from severe pain during even light physical activity.
While many opt for joint replacements and various in-depth surgeries every year, more and more people understand the vast array of uses and benefits from regenerative medicine. This process takes advantage of the major steps made in medical care in recent years, providing patients in Los Angeles withnewer and more effective treatments.
Whether you have been suffering from orthopedic conditions for years or are only just beginning to feel the toll on your joints, regenerative medicinetreatment may be right for you. Los Angeles Orthopedic surgeon Steven W. Meier, MD and the team at Meier Orthopedic Sports and Regenerative Medicine provide numerous forms of regenerative medicine treatment in order to help patients put an end to countless physical limitations. To learn more about regenerative medicine treatment techniques and schedule an appointment with an experienced orthopedic surgeon, call 310.736.2793 or contact us online today.
Rather than replace missing tissue in joints with artificial materials, joint regenerative medicine focuses solely on regenerating tissue, tendons, cartilage, bone, and ligaments. Whether these tissues have been severely damaged or have lost considerable mass, regenerative techniques aim to restore important tissue to a healthier and younger state.
In order to provide the most effective treatments possible for each patients unique orthopedic condition, Dr. Meier in Los Angeles provides three main modalities of regenerative medicine. Each of these treatments regrows tissue in a different manner and may be most suitable for certain conditions.
Because orthopedic conditions can cause severe pain that limits activities during both professional and personal life, prolotherapy treatment is designed to alleviate serious discomfort in a natural manner. During prolotherapy treatment, a solution that includes dextrose is injected between the muscles and bone where the injury has taken place. A numbing spray is used during the treatment, making this a painless procedure.
The solution that is injected into the problem area not only quickly alleviates painbut is designed to stimulate the production of tendons and ligaments. Additionally, the immune system will be stimulated, bringing fibroblasts into the areas where pain occurs, which will both eliminate pain and grow soft tissue.
Depending on the type and severity of an injury, a patient may undergo multiple prolotherapy treatments. However, the total healing time is often far shorter and much less complicated than post-surgery rehabilitation. With the help of a skilled orthopedic surgeon, a Prolotherapy treatment plan can be tailored to your unique orthopedic condition.
As an orthopedic surgeonwho practices the use of prolotherapy, Dr. Meier provides a rare combination of skills, as prolotherapy in Los Angeles is not normally part of the standard orthopedic surgery training curriculum. In addition, the combination of prolotherapy use with surgery skills is advantageous, as a surgeon has detailed knowledge of anatomical structure. The combination of a high level of technical skill and experience performing prolotherapy treatment means there is a reduced risk of complications and can also reduce the total amount of treatments needed for effective prolotherapy care. Additional information about regenerative medicine treatment can be found on ourprolotherapy FAQ.
Stem cells are the building blocks of the human body. Modern scientific research has shown that stem cells are used by the body to turn into anything that is needed on a daily basis. However, the human body is not equipped to create replacement tissues for orthopedic injuries on its own.
Through orthopedic stem cell treatment therapy, we use these cells to grow tissue has been damaged or lost. The amniotic stem cells have the ability to grow into nearly any type of tissue in little time, thanks to modern medical procedures. By doing so, we can specifically create what your joints need in order to return them to a healthy and properly functioning state.
Additionally, the use of platelet-rich plasma (PRP) therapy in stem cell treatments allows orthopedic surgeons to supercharge self-healing capabilities. During this procedure, blood will be drawn from the patient, then spun down to concentrated platelets and growth factors. This concentrated plasma will then be injected directly into the injured joint, tendon, or ligament, which will expose damage to this natural healing solution. PRP therapy treatment is among the most modern and cutting edge of all procedures available.medlineplus.gov has more information about stem cell therapy as well.
There are numerous conditions that can be treated with PRP Therapy. While no two patients will undergo the same treatment for their needs, knowing what conditions are treatable through regenerative medicine treatment can help you make an informed decision concerning your path to recovery.
The following orthopedic conditions can all be treated through various forms of regenerative medicine:
Should you be suffering from symptoms indicating that you have any of these conditions, or if you have been diagnosed with a condition, it is vital that you seek help from a skilled orthopedic surgeon. Dr. Steven W. Meier of Los Angeles not only provides regenerative medicine injection therapy and a wide variety of orthopedic services, he also provides second opinions on diagnoses in order to give patients the most information possible on their conditions to obtain proper joint tissue regeneration.
If you are looking for a solution to assist with your orthopedic limitations, get in touch with Dr. Steven W. Meier and the medical team at Meier Orthopedic Sports and Regenerative Medicine. Dr. Meier is a Board-certified orthopedic surgeon with years of experience in advanced orthopedic techniques.
For more information on regenerative medicine and what treatments may be right for you, contact an orthopedic surgeon by calling 310.736.2793 or filling out the online contact form. Through an appointment with a regenerative medicine specialist at Meier Orthopedic Sports and Regenerative Medicine in Los Angeles, you can restore your body and stay healthy for years to come.
Next, learn about our Lipogems.
Read the rest here:
Regenerative Medicine Therapy Specialists Beverly Hills, Los ...
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023
- Active Wound Care Market Rising demand for Skin Substitutes to boost the industry (2023-2033) | CAGR of 5.5% - EIN News - March 21st, 2023
- Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% - By PMI - EIN News - March 21st, 2023
- ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical VHH to address an unmet medical... - February 8th, 2023
- A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field - Yahoo Finance - October 15th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 15th, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 15th, 2022
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 15th, 2022
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 15th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - GlobeNewswire - October 15th, 2022
- Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022 -... - October 15th, 2022
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 15th, 2022
- Cell therapy weekly: Ray Therapeutics and Forge Biologics expand partnership - RegMedNet - October 15th, 2022
- FDA Expands Oversight of Cell and Gene Therapies - Pharmaceutical Technology Magazine - October 15th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Business Wire - October 15th, 2022
- The Health Benefits Of Sea Moss, According To Experts - Forbes - October 15th, 2022
- ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of ... - The Bakersfield Californian - October 15th, 2022
- Pain Management & Regenerative Medicine Specialists DFW - September 4th, 2022
- Tissue Engineering and Regenerative Medicine - National Institute of ... - September 4th, 2022
- First U.S. patient receives autologous stem cell therapy to treat dry AMD - National Institutes of Health (.gov) - September 4th, 2022
- International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt - Construction Review - September 4th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - September 4th, 2022
- Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic - BioSpace - September 4th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 4th, 2022
- TikoMed's ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all... - September 4th, 2022
- Frequency Therapeutics to Participate in September Investor and Medical Conferences - Business Wire - September 4th, 2022
- Can the immortal jellyfish teach us how to reverse aging? - Earth.com - September 4th, 2022
- Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy - Business Wire - September 4th, 2022
- Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors - PR Newswire - September 4th, 2022
- Rise In Number Of CROS In Various Regions Such As Europe Is Expected To Fuel The Growth Of Induced Pluripotent Stem Cell Market At An Impressive CAGR... - September 4th, 2022
- Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com -... - August 19th, 2022
- Pain Relief Treatments: The Benefits of Regenerative Medicine From Head to Toe - 30Seconds.com - August 19th, 2022
- FDA Issues Draft Guidance to Facilitate Development of Human Gene Therapy, CAR T Cell, and Regenerative Medicine Products - Wilson Sonsini Goodrich... - August 19th, 2022
- Marco Quarta to present at the 9th Aging Research & Drug Discovery Meeting 2022 - EurekAlert - August 19th, 2022